Directory
>
Pete Rahl
Pete Rahl
Research Assistant
Massachusetts, Cambridge, United States
Pete Rahl
Summary
Pete Rahl is an accomplished molecular biologist and executive director at Kronos Bio, Inc., with a robust background in genomics, chemical biology, and drug discovery. His career spans multiple roles in prestigious organizations, including Syros Pharmaceuticals and Fulcrum Therapeutics, where he has led teams in developing innovative therapies for cancer and genetic disorders. With 23 publications in high-impact journals and several patents to his name, Pete's contributions to the field are significant. His training at Cornell University and the Whitehead Institute at MIT has laid a strong foundation for his research endeavors. He is known for his strategic thinking and ability to drive projects from conception to clinical development. Beyond his technical expertise, Pete is passionate about mentoring the next generation of scientists and fostering collaborative research environments. His work has not only advanced scientific knowledge but also has the potential to impact patient care significantly.
Pete Rahl
Work Experience
Vice President, Biology at
Stealth Mode Biotech, incubated at Foresite Labs
August 2025 - Present
Pete Rahl
Education
Cornell University, Ph.D., Pharmacology
January 2002 - January 2007
Merrimack College, B.S., Biochemistry
January 1998 - January 2002
Robert E. Fitch High School
January 1994 - January 1998
Frequently Asked Questions about Pete Rahl
What is Pete Rahl email address?
Pete Rahl's primary email address is *********@kronosbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
Where Pete Rahl graduated from?
Pete Rahl holds a degree in Department of Molecular Medicine from Cornell University.
How can I directly contact Pete Rahl?
To contact Pete Rahl directly, you can use the email address *********@kronosbio.com. Complete contact information is available upon registration with Muraena.
Who is Pete Rahl?
Pete Rahl is an accomplished molecular biologist and executive director at Kronos Bio, Inc., with a robust background in genomics, chemical biology, and drug discovery. His career spans multiple roles in prestigious organizations, including Syros Pharmaceuticals and Fulcrum Therapeutics, where he has led teams in developing innovative therapies for cancer and genetic disorders. With 23 publications in high-impact journals and several patents to his name, Pete's contributions to the field are significant. His training at Cornell University and the Whitehead Institute at MIT has laid a strong foundation for his research endeavors. He is known for his strategic thinking and ability to drive projects from conception to clinical development. Beyond his technical expertise, Pete is passionate about mentoring the next generation of scientists and fostering collaborative research environments. His work has not only advanced scientific knowledge but also has the potential to impact patient care significantly.
Pete`s contact details
*********@kronosbio.com